Emerging Tech
How AI is Accelerating Drug Discovery and Vaccine Development
In a remarkable acceleration, AI helped Insilico achieve a 30-month sprint from target identification to a Phase I clinical trial candidate, a process that traditionally takes years longer, according
Helena Strauss·June 6, 2026
